Glide SDI^® | Applications

For protein-based therapeutics that cannot be taken orally, Glide offers a means to inject stable, solid formulations
E.g. insulin, erythropoietin

Opportunity to deliver stable solid formulations through the skin, improving drug delivery; offers product differentiation and patent extension options
E.g. interferon alpha, interferon beta

Quick, easy, clean and safe to use at home with minimal training; no sharps disposal required and stable solid formulation may not require refrigeration
E.g. human growth hormone, migraine treatments

Solid injection requires no needle and avoids need for expensive and complicated packaging to transport fluid; solid formulation may not require refrigeration; easy large scale, low cost manufacturing potential; non-clinical data (e.g. influenza) suggest enhanced immune response for antigens delivered with the Glide SDI
E.g. hepatitis B, measles, tuberculosis, influenza

Quick, easy and clean administration, can be carried out with minimal training; easy to store and carry, with long-term stability
E.g. adrenalin, glucagon

Quick, easy and clean administration with minimal training; low cost manufacture on a large scale; stable formulations can be stockpiled
E.g. smallpox and influenza vaccines

Heat-stable formulations (no cold-chain required); low-cost manufacture on large scale; quick, easy and clean administration with minimal training
E.g. vaccines, paediatric formulations